Rsv F Protein Compositions And Methods For Making Same

Patent No. EP4183412 (titled "Rsv F Protein Compositions And Methods For Making Same") was filed by GlaxoSmithKline Biologicals SA on Jul 15, 2010. The application was issued on Aug 14, 2024.

UPC Cases New

Latest UPC cases involving this patent.

Case Number	Filing Date	Plaintiff	Proceeding Type
UPC_CFI_687/2024	Nov 15, 2024	Pfizer	Counter Claim For Revocation
UPC_CFI_476/2024	Aug 14, 2024	Pfizer	Revocation
UPC_CFI_468/2024	Aug 5, 2024	GlaxoSmithKline Biologicals SA	Infringement

Patent Family

Statuses, jurisdictions and citation links are shared on request.

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Jun 18, 2025
Communication regarding the expiry of opposition period
Aug 27, 2024
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jul 18, 2024
Decision to grant a European patent
Jul 9, 2024
(Electronic) Receipt
Jul 9, 2024
Filing of the translations of the claims
Jul 9, 2024
French translation of claims
Jul 9, 2024
German translation of the claims
Jul 9, 2024
Letter accompanying subsequently filed items
May 6, 2024
Annex to the communication about intention to grant a European patent
May 6, 2024
Bibliographic data of the European patent application
May 6, 2024
Communication about intention to grant a European patent
May 6, 2024
Intention to grant (signatures)
May 6, 2024
Text intended for grant (clean copy)
May 6, 2024
Text intended for grant (version for approval)
Apr 19, 2024
(Electronic) Receipt
Apr 19, 2024
Amended claims with annotations
Apr 19, 2024
Claims
Apr 19, 2024
Letter accompanying subsequently filed items
Apr 19, 2024
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Apr 5, 2024
Annex to the communication about intention to grant a European patent
Apr 5, 2024
Bibliographic data of the European patent application
Apr 5, 2024
Communication about intention to grant a European patent
Apr 5, 2024
Intention to grant (signatures)
Apr 5, 2024
Text intended for grant (clean copy)
Apr 5, 2024
Text intended for grant (version for approval)
Feb 9, 2024
(Electronic) Receipt
Feb 9, 2024
Letter accompanying subsequently filed items
Feb 9, 2024
Non-patent literature cited during the examination procedure
Feb 9, 2024
Reply to communication from the Examining Division
Jan 26, 2024
Annex to the communication
Jan 26, 2024
Communication from the Examining Division
Dec 18, 2023
(Electronic) Receipt
Dec 18, 2023
Amended claims with annotations
Dec 18, 2023
Amended description with annotations
Dec 18, 2023
Claims
Dec 18, 2023
Description
Dec 18, 2023
Letter accompanying subsequently filed items
Dec 18, 2023
Reply to communication from the Examining Division
Dec 14, 2023
Annex to the communication
Dec 14, 2023
Communication from the Examining Division
Dec 4, 2023
Annex to the communication
Dec 4, 2023
Consultation by telephone/in person
Dec 4, 2023
Result of consultation by telephone/in person
Nov 24, 2023
(Electronic) Receipt
Nov 24, 2023
Annex
Nov 24, 2023
Letter accompanying subsequently filed items
Nov 24, 2023
Matter concerning the application
Oct 9, 2023
(Electronic) Receipt
Oct 9, 2023
Amended claims with annotations
Oct 9, 2023
Amended description with annotations
Oct 9, 2023
Annex
Oct 9, 2023
Claims
Oct 9, 2023
Description
Oct 9, 2023
Letter accompanying subsequently filed items
Oct 9, 2023
Reply to communication from the Examining Division
Sep 4, 2023
Grant of extension of time limit (examination procedure)
Aug 29, 2023
(Electronic) Receipt
Aug 29, 2023
Letter accompanying subsequently filed items
Aug 29, 2023
Request for extension of time limit to communication from the Examining Division
May 30, 2023
Information about publication, reminder payment of designation fee, response to extended European search report, if applicable
Apr 26, 2023
Notification of forthcoming publication
Apr 19, 2023
Annex to the communication
Apr 19, 2023
Communication from the Examining Division
Apr 13, 2023
Refund of fees
Apr 6, 2023
Communication regarding the transmission of the European search report
Apr 6, 2023
European search report
Apr 6, 2023
Information on Search Strategy
Nov 18, 2022
Communication confirming withdrawal from representation
Nov 18, 2022
Communication of amended entries concerning the representative
Nov 1, 2022
(Electronic) Receipt
Nov 1, 2022
Letter accompanying subsequently filed items
Nov 1, 2022
Submission concerning change of applicant's representative
Oct 12, 2022
(Electronic) Receipt
Oct 12, 2022
Letter accompanying subsequently filed items
Oct 10, 2022
Abstract
Oct 10, 2022
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
Oct 10, 2022
Annex
Oct 10, 2022
Claims
Oct 10, 2022
Converted Sequence Listing
Oct 10, 2022
Description
Oct 10, 2022
Designation of inventor
Oct 10, 2022
Drawings
Oct 10, 2022
Matter concerning the application
Oct 10, 2022
Request for grant of a European patent
Feb 14, 2011
Priority document (electronically transmitted)
Feb 14, 2011
Priority document (electronically transmitted)

EP4183412

GLAXOSMITHKLINE BIOLOGICALS SA

Application Number: EP22200670A
Filing Date: Jul 15, 2010
Status: No Opposition Filed Within Time Limit; Jun 20, 2025
Publication Date: Aug 14, 2024
External Links: Slate, Register , Google Patents

IP Verse

Rsv F Protein Compositions And Methods For Making Same

Patent Summary

UPC Cases New

Patent Family

Dossier Documents

EP4183412